Literature DB >> 29478361

Hepatic rupture associated with preeclampsia, report of three cases and literature review.

María Fernanda Escobar Vidarte1, Daniela Montes2, Alejandra Pérez2, Sara Loaiza-Osorio3, Albaro José Nieto Calvache1.   

Abstract

BACKGROUND: Hepatic rupture is a complication during pregnancy that, although rare, accounts for high morbidity and mortality rates. It is mainly associated with severe preeclampsia and HELLP syndrome. Incidence is estimated to be at one per 67,000 births or one per 2000 patients with preeclampsia/eclampsia/HELLP, mainly in multiparous women; women in their 40s; after 32 weeks of gestation; and during the first 15 h postpartum. CASES: This article exposes the institutional experience at Fundación Valle del Lili in Cali, Colombia, in managing and treating hepatic rupture associated with severe preeclampsia and HELLP syndrome in three patients in the 30th, the 26th, and the 27th week of gestation, not resulting in maternal death. DISCUSSION: A search in Pubmed, Embase, and Ovid from 2000 to 2017 resulted in 35 cases reported in either pregnant or puerperal women. Hepatic rupture is a rare complication in pregnancy associated with preeclampsia and HELLP syndrome. Its pathophysiology is attributed to the presence of vasospasm due to an increase in concentration and sensitivity to circulating vasopressors during pregnancy. There is no standard management, but surgery reduces mortality significantly. It includes endovascular management, partial hepatectomy, or transplant (only one patient required a liver transplant in our search). The most used techniques have been ligation of the hepatic artery, embolization of the hepatic artery, and examination, packing, and drainage of hepatic lesion for bleeding control (27 cases were treated with laparotomy with evacuation of hematoma and hemostasis and four cases were treated with embolization of the hepatic artery). Hepatic artery occlusion both by surgery ligation and by embolization through interventional radiology has reported successful and failing results during pregnancy
Conclusion: Management of pathologies as hepatic rupture associated with severe preeclampsia and HELLP syndrome has to be clearly protocolized for prompt diagnosis and early management. Furthermore, it has to be carried out through multidisciplinary teams in high-complexity obstetrics scenarios.

Entities:  

Keywords:  Gastrointestinal hemorrhage; HELLP syndrome; hepatic rupture; high risk; hypertension; pregnancy; pregnancy-induced; severe preeclampsia

Year:  2018        PMID: 29478361     DOI: 10.1080/14767058.2018.1446209

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  6 in total

1.  Hypertensive disorders in pregnancy complicated by liver rupture or hematoma: a systematic review of 391 reported cases.

Authors:  Goran Augustin; Matija Hadzic; Josip Juras; Slavko Oreskovic
Journal:  World J Emerg Surg       Date:  2022-07-08       Impact factor: 8.165

Review 2.  Maternal critical care: part II.

Authors:  A Banerjee; S Cantellow
Journal:  BJA Educ       Date:  2021-02-06

Review 3.  Non-obstetric complications in preeclampsia.

Authors:  Katarzyna Pankiewicz; Ewa Szczerba; Tomasz Maciejewski; Anna Fijałkowska
Journal:  Prz Menopauzalny       Date:  2019-06-14

Review 4.  Managing hepatic complications of pregnancy: practical strategies for clinicians.

Authors:  Maura Alice Morrison; Yooyun Chung; Michael A Heneghan
Journal:  BMJ Open Gastroenterol       Date:  2022-03

5.  Subcapsular Liver Hematoma: A Rare Complication of Hemolysis, Elevated Liver Enzymes, and Low Platelets (HELLP) Syndrome Managed Conservatively.

Authors:  Stylianos Grigorakis; George N Tzimas; Chalent Alexakis; Beatrice E Morea; Nikolaos Kontomitros
Journal:  Cureus       Date:  2022-02-09

6.  A Rare Case of HELLP Syndrome with Hematomas of Spleen and Liver, Eclampsia, Severe Hypertension and Prolonged Coagulopathy-A Case Report.

Authors:  Małgorzata Lewandowska; Monika Englert-Golon; Zbigniew Krasiński; Paweł Piotr Jagodziński; Stefan Sajdak
Journal:  Int J Environ Res Public Health       Date:  2022-06-23       Impact factor: 4.614

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.